- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03000725
Adapting Project UPLIFT for Hispanic Patients With Epilepsy II
Adapting Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is for Hispanic Patients With Epilepsy II
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The goal of this study is to adapt Project UPLIFT for Hispanic adults with epilepsy and depression. A 2-arm randomized control trial will be conducted to evaluate the feasibility, acceptability and effects of Project UPLIFT versus usual care (UC) in Hispanic patients with epilepsy.
The specific aim of this study is: To evaluate the feasibility, acceptability and short- and long-term effects of the adapted intervention on depression and other outcomes in 72 English- and Spanish-speaking Hispanic epilepsy patients.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- self-identified as Hispanic
- English or Spanish speaking
- diagnosis of epilepsy for at least one year post diagnosis
- willing to participate in 8 one-hour telephone sessions every week for eight weeks.
- willing to be audio-taped
- Elevated depressive symptoms (Center for Epidemiological Studies Depression Scale (CES-D) score >13
Exclusion Criteria:
- Severe depression (CES-D > 37)
- Active suicidal ideation
- Significant cognitive impairment (evident during screening)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: UPLIFT
Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a home-based intervention that teaches cognitive and mindfulness skills to people with epilepsy by phone to reduce their depression and improve quality of life (QOL).
|
Description of the UPLIFT program: Participants who choose to participate in UPLIFT will complete 8 weekly group sessions via telephone. Session 1: Introduction to UPLIFT/Noticing Thoughts Session 2: Checking and Changing Thoughts Session 3: Coping & Relaxing Session 4: Attention & Mindfulness Session 5: The Present as a Calm Place Session 6: Thoughts as Changeable, Thoughts as Not Fixed Session 7: Focus on Pleasure & the Importance of Reinforcement Session 8: Preventing Lapses and Giving Thanks |
|
Active Comparator: USUAL CARE
Participants randomized to the UC group will receive printed educational materials on management of epilepsy in English or Spanish as preferred.
|
Participants randomized to the UC group will receive printed educational materials on management of epilepsy in English or Spanish as preferred.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire (PHQ-9)
Time Frame: 12 Months
|
This measure assesses depressive symptoms in the past two weeks based on DSM-IV diagnostic criteria for major depression.
|
12 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality Of Life in Epilepsy (QOLIE-10)
Time Frame: 12 Months
|
This measure assesses health-related quality of life for adults with epilepsy.
|
12 Months
|
|
PROMIS-Global
Time Frame: 12 Months
|
This 10-item measure was developed by NIH to assess physical, mental and social functioning.
It is a generic rather than disease-specific measure of global health.
|
12 Months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Work Productivity and Activity Impairment Questionnaire (WPAI)
Time Frame: 12 Months
|
This self-report measure assesses the impact of disease on productivity and work productivity loss due to general health or a specified health problem.
|
12 Months
|
|
Self-Compassion Scale (SCS)
Time Frame: 12 Months
|
This measure assesses trait levels of self-compassion, including the thoughts, emotions and behaviors associated with the various components of self-compassion.
|
12 Months
|
|
Satisfaction with Life Scale (SWLS)
Time Frame: 12 Months
|
This 5-item instrument measures global cognitive judgments of satisfaction with one's life.
|
12 Months
|
|
Interpersonal Support Evaluation List (ISEL)
Time Frame: 12 Months
|
This measure assesses the perceived availability of appraisal, belonging and tangible social support.
|
12 Months
|
|
Five Facet Mindfulness Questionnaire Description (FFMQ) Short form
Time Frame: 12 Months
|
This 24-item measure assesses the construct of mindfulness through five component skills: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience.
|
12 Months
|
|
Ruminative Responses Scale (RRS)
Time Frame: 12 Months
|
This 22-item scale assesses cognitive responses to depressed mood.
|
12 Months
|
|
Perceived Stress Scale (PSS-10)
Time Frame: 12 Months
|
This 10-item measure assesses the degree to which situations in one's life are appraised as stressful or overwhelming.
|
12 Months
|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: 12 Months
|
This 19-item questionnaire assesses sleep quality over the past month.
|
12 Months
|
|
Epilepsy Stigma Scale
Time Frame: 12 Months
|
This 10-item measure assesses the degree to which a person believes that epilepsy is perceived as negative and interferes with relationships with others.
|
12 Months
|
|
Healthcare Utilization
Time Frame: 12 Months
|
This self-report questionnaire assesses the use of healthcare services (e.g., clinic visits ED visits, etc).
|
12 Months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tanya Spruill, NYU Langone Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-01531
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustNot yet recruitingEpilepsy Intractable | Epilepsy in Children
-
University Hospital, LilleCompletedFocal Epilepsy | Epilepsy IntractableFrance
-
Massachusetts General HospitalBoston University; National Institute of Neurological Disorders and Stroke...CompletedEpilepsy | Epilepsy; Seizure | Rolandic Epilepsy | Rolandic Epilepsy, Benign | Centrotemporal Epilepsy | Centrotemporal; EEG Spikes, Epilepsy of ChildhoodUnited States
Clinical Trials on Using Practice and Learning to Increase Favorable Thoughts
-
NYU Langone HealthRecruiting
-
University of Colorado, DenverCompleted
-
Women's College HospitalInstitute for Clinical Evaluative Sciences; Ontario HealthCompletedVaccine Uptake | Covid19 VaccinationCanada
-
Cairo UniversityCompletedDiplegic Spastic Cerebral PalsyEgypt
-
University of MinnesotaRecruiting
-
Jacques GaumeSwiss National Science Foundation; Apptitude; Addiction SwitzerlandEnrolling by invitationCannabis Use | Harm ReductionSwitzerland
-
St. Antonius HospitalActive, not recruitingBreast CancerNetherlands, Italy
-
American Board of Internal MedicineThe Josiah Macy, Jr. FoundationCompleted
-
Ottawa Heart Institute Research CorporationThe Change FoundationCompletedMedication Adherence | Acute Coronary SyndromeCanada
-
Memorial Sloan Kettering Cancer CenterTerminatedFibrillation | Post-Operative Cancer Patients Experiencing AtrialUnited States